Home > Annual Financials > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES Financial Statement Analysis
[BOM: 524518|NSE : KREBSBIO]

The Revenues of KREBS BIOCHEMICALS & INDUSTRIES have decreased by -3.28% YoY .
The Earnings Per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

KREBS BIOCHEMICALS & INDUSTRIES Last 5 Annual Financial Results
[BOM: 524518|NSE : KREBSBIO]

StandaloneMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹50 Cr₹52 Cr₹60 Cr₹54 Cr₹33 Cr
Expenses ₹59 Cr₹68 Cr₹94 Cr₹71 Cr₹52 Cr
Operating Profit (Excl OI) ₹-8.72 Cr₹-16 Cr₹-34 Cr₹-18 Cr₹-19 Cr
Other Income ₹0.45 Cr₹0.62 Cr₹1.16 Cr₹0.62 Cr₹0.37 Cr
Interest ₹4.69 Cr₹2.97 Cr₹5.39 Cr₹6.28 Cr₹6.00 Cr
Depreciation ₹6.77 Cr₹6.56 Cr₹6.30 Cr₹5.12 Cr₹4.68 Cr
Profit Before Tax ₹-20 Cr₹-25 Cr₹-45 Cr₹-28 Cr₹-29 Cr
Profit After Tax ₹-20 Cr₹-25 Cr₹-45 Cr₹-28 Cr₹-29 Cr
Earnings Per Share (Rs)₹-9.15₹-11.45₹-20.65₹-14.45₹-16.04
PAT Margin (%)-39.13-47.36-74.58-52.81-86.41
ROE(%)0.000.000.000.000.00
ROCE(%)-18.99-28.59-57.38-40.28-56.96
Total Debt/Equity(x)-1.62-1.84-1.91-2.37-2.03

Key Financials

Market Cap : ₹ 216.0 Cr
Revenue (TTM) : ₹ 49.2 Cr
Net Profit(TTM) : ₹ -24.5 Cr
EPS (TTM) : ₹ -11.4
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
KREBS BIOCHEMICALS & INDUSTRIES 1.9% 5.3% 38.8%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -4.6% 20.7%
CIPLA -2.9% -3.9% 1.1%
DR REDDYS LABORATORIES 0.9% -10.4% 0.1%
ZYDUS LIFESCIENCES 0.9% -0.3% 27.9%
DIVIS LABORATORIES 9.8% 4.5% 64.7%
MANKIND PHARMA 1.9% -13.7% 24%
TORRENT PHARMACEUTICALS -4.4% -6.3% 17.5%
LUPIN 5.1% -2.9% 34.2%


KREBS BIOCHEMICALS & INDUSTRIES Revenues
[BOM: 524518|NSE : KREBSBIO]

Y-o-Y

-3.28 %

5 Yr CAGR

10.84 %

Years Revenues % Change
Mar2024 ₹50 Cr
-3.28
Mar2023 ₹52 Cr
-12.68
Mar2022 ₹60 Cr
11.18
Mar2021 ₹54 Cr
60.72
Mar2020 ₹33 Cr -


KREBS BIOCHEMICALS & INDUSTRIES Operating Profit
[BOM: 524518|NSE : KREBSBIO]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2024 ₹-8.72 Cr
Negative
Mar2023 ₹-16 Cr
Negative
Mar2022 ₹-34 Cr
Negative
Mar2021 ₹-18 Cr
Negative
Mar2020 ₹-19 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2024 -17.3%
Negative
Mar2023 -30.27%
Negative
Mar2022 -56.94%
Negative
Mar2021 -32.73%
Negative
Mar2020 -55.53% -

KREBS BIOCHEMICALS & INDUSTRIES Profit After Tax
[BOM: 524518|NSE : KREBSBIO]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2024 ₹-20 Cr
Negative
Mar2023 ₹-25 Cr
Negative
Mar2022 ₹-45 Cr
Negative
Mar2021 ₹-28 Cr
Negative
Mar2020 ₹-29 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2024 -39.13 %
Negative
Mar2023 -47.36 %
Negative
Mar2022 -74.58 %
Negative
Mar2021 -52.81 %
Negative
Mar2020 -86.41 % -

KREBS BIOCHEMICALS & INDUSTRIES Earnings Per Share (EPS)
[BOM: 524518|NSE : KREBSBIO]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2024 ₹-9.15
Negative
Mar2023 ₹-11
Negative
Mar2022 ₹-21
Negative
Mar2021 ₹-14
Negative
Mar2020 ₹-16 -

KREBS BIOCHEMICALS & INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 524518|NSE : KREBSBIO]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2024 -18.99%
Negative
Mar2023 -28.59%
Negative
Mar2022 -57.38%
Negative
Mar2021 -40.28%
Negative
Mar2020 -56.96% -

KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex

Current Share Price : ₹100.0
Current MarketCap: ₹ 216.0 Cr
Updated EOD on :Feb 05,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES

1.9%

5.3%

38.8%

SENSEX

2%

0.1%

8.6%

KREBS BIOCHEMICALS & INDUSTRIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about KREBS BIOCHEMICALS & INDUSTRIES Financials


How the annual revenues of KREBS BIOCHEMICALS & INDUSTRIES have changed ?

The Revenues of KREBS BIOCHEMICALS & INDUSTRIES have decreased by -3.28% YoY .

How the Earnings per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES have changed?

The Earnings Per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES has decreased by Negative YoY .